Inhibitory effects of tandospirone, a 5-HT1A agonist, on medial vestibular nucleus neurons responding to lateral roll tilt stimulation in rats

被引:12
作者
Amano, T [1 ]
Akbar, M [1 ]
Matsubayashi, H [1 ]
Sasa, M [1 ]
机构
[1] Hiroshima Univ, Sch Med, Dept Pharmacol, Hiroshima 7348551, Japan
关键词
tandospirone; WAY-100635; lateral roll tilt; 5-HT1A; medial vestibular nucleus neuron;
D O I
10.1016/S0006-8993(01)02698-1
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
An electrophysiological study was performed using chloral hydrate-anesthetized rats to determine whether tandospirone, a 5-HT1A agonist, affects neuronal activities of the medial vestibular nucleus (MVN), since serotonergic innervation and 5-HT1A receptors are present in this nucleus. Tandospirone applied microiontophoretically at a current of 20-60 nA caused an inhibition of tilt-induced firing of alpha -type neurons, which showed increased and decreased firing with lateral tilt ipsilateral and contralateral to the recording site, respectively, along with that of beta -type neurons which exhibited the reverse responses to ipsilateral and contralateral tilt stimulation. The inhibition was antagonized during simultaneous, iontophoretic application of WAY-100635 (20-60 nA), a 5-HT1A receptor antagonist, although WAY-100635 alone rarely affected spontaneous or tilt-induced firing in either type of neurons. These results suggest that tandospirone acts on a 5-HT1A receptor to inhibit transmission of otolith information to alpha- and beta -type MVN neurons. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:195 / 198
页数:4
相关论文
共 26 条
[1]
Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties [J].
Assie, MB ;
Koek, W .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 304 (1-3) :15-21
[2]
A review of central 5-HT receptors and their function [J].
Barnes, NM ;
Sharp, T .
NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152
[3]
MODIFICATION OF SYNAPTIC INPUT FOLLOWING UNILATERAL LABYRINTHECTOMY [J].
DIERINGER, N ;
PRECHT, W .
NATURE, 1977, 269 (5627) :431-433
[4]
Characterization of 5-HT1A receptor functional coupling in cells expressing the human 5-HT1A receptor as assessed with the cytosensor microphysiometer [J].
Dunlop, J ;
Zhang, YX ;
Smith, DL ;
Schechter, LE .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1998, 40 (01) :47-55
[5]
Fletcher A, 1996, BEHAV BRAIN RES, V73, P337
[6]
A PHARMACOLOGICAL PROFILE OF THE SELECTIVE SILENT 5-HT1A RECEPTOR ANTAGONIST, WAY-100635 [J].
FORSTER, EA ;
CLIFFE, IA ;
BILL, DJ ;
DOVER, GM ;
JONES, D ;
REILLY, Y ;
FLETCHER, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (01) :81-88
[7]
TANDOSPIRONE AND ITS METABOLITE, 1-(2-PYRIMIDINYL)-PIPERAZINE .1. EFFECTS OF ACUTE AND LONG-TERM ADMINISTRATION OF TANDOSPIRONE ON SEROTONIN NEUROTRANSMISSION [J].
GODBOUT, R ;
CHAPUT, Y ;
BLIER, P ;
DEMONTIGNY, C .
NEUROPHARMACOLOGY, 1991, 30 (07) :679-690
[8]
INHIBITION OF HIPPOCAMPAL CA1 NEURONS BY 5-HYDROXYTRYPTAMINE, DERIVED FROM THE DORSAL RAPHE NUCLEUS AND THE 5-HYDROXYTRYPTAMINE-1A AGONIST SM-3997 [J].
HIROSE, A ;
SASA, M ;
AKAIKE, A ;
TAKAORI, S .
NEUROPHARMACOLOGY, 1990, 29 (02) :93-101
[9]
JOHNSTON AR, 1993, EXP BRAIN RES, V93, P293
[10]
INVOLVEMENT OF THE DORSAL HIPPOCAMPUS IN MEDIATION OF THE ANTIANXIETY ACTION OF TANDOSPIRONE, A 5-HYDROXYTRYPTAMINE1A AGONISTIC ANXIOLYTIC [J].
KATAOKA, Y ;
SHIBATA, K ;
MIYAZAKI, A ;
INOUE, Y ;
TOMINAGA, K ;
KOIZUMI, S ;
UEKI, S .
NEUROPHARMACOLOGY, 1991, 30 (05) :475-480